Welcome to the SIENNA clinical study!

Learn about the SIENNA clinical study

Is GA affecting you or your loved one's daily life?

This website provides information about a clinical study, SIENNA, for adults with GA. GA is a medical term that refers to later-stage cases of age-related macular degeneration (AMD) which is an eye condition affecting central vision (what one sees straight ahead) and is a leading cause of blindness among people over 50 years of age. GA is a progressive condition (it gets worse with time) and affects about 5 million people worldwide. 

Please note that this clinical trial will use investigational drug products, the safety and efficacy of which has not been fully evaluated by Regulatory Authorities. One of the investigational drug products has been approved for certain uses in some countries. Please consult with the study physician for more information.

Clinical studies are essential to investigating potential treatments and are not possible without the people who take part. Everyone involved in this clinical study plays an important role in increasing our understanding of GA, which may help others in the future with this condition.

Living with GA may feel overwhelming, and you may feel that you have enough to do without committing to a clinical study. However, you may play a key role in helping to develop therapies that are being studied to help slow the progression of GA. Every treatment that exists today is available because of study participants who actively took part in research.

Learn more about the SIENNA study and see if it may an option for you.